Fanconi anemia: cellular and molecular features;L'anémie de Fanconi : aspects cellulaires et moléculaires

Pathologie Biologie

Volumn 55, Issue 1, 2007, Pages 19-28

  Mace G ^a   Briot, D ^a   Guervilly, J H ^a   Rosselli, F ^a  

^a CNRS   (France)

Author keywords

DNA interstrands crosslinks; DNA repair; FANC BRCA pathway; Fanconi anemia; Oxidative damage; TNF

Indexed keywords

DNA; FANCONI ANEMIA PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CANCER SUSCEPTIBILITY; CELL FUNCTION; CELL PROTECTION; FANCONI ANEMIA; GENE IDENTIFICATION; HUMAN; OXIDATIVE STRESS; PROTEIN FUNCTION;

BONE MARROW TRANSPLANTATION; CHROMOSOMES, HUMAN; CROSS-LINKING REAGENTS; DNA; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENE THERAPY; GENES, RECESSIVE; GENETIC COMPLEMENTATION TEST; GENETIC HETEROGENEITY; HEMATOPOIESIS; HOMEOSTASIS; HUMANS; MUTAGENS; OXIDATIVE STRESS; PHENOTYPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33846804448     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2006.04.008     Document Type: Article

References (105)

1. Fanconi G. Familiäre infantile perniziosaartige anämie (pernizioses blutbild und konstitution). Jahrbuch Kinderhilkd 117 (1927) 257-280
2. Young N.S., and Alter B. Clinical features of fanconi's anemia. Aplastic Anemia, Acquired and Inherited (1994), W. B. Saunders Company, Philadelphia 275-279
3. Tischkowitz M., and Dokal I. Fanconi anaemia and leukaemia: clinical and molecular aspects. Br. J. Haematol. 126 2 (2004) 176-191
4. Wagner J.E., Tolar J., Levran O., Scholl T., Deffenbaugh A., Satagopan J., et al. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 103 8 (2004) 3226-3229
5. Alter B.P. Fanconi's anaemia and its variability. Br. J. Haematol. 85 1 (1993) 9-14
6. Faivre L., Guardiola P., Lewis C., Dokal I., Ebell W., Zatterale A., et al. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood 96 13 (2000) 4064-4070
7. Tischkowitz M.D., and Hodgson S.V. Fanconi anaemia. J. Med. Genet. 40 1 (2003) 1-10
8. Gillio A.P., Verlander P.C., Batish S.D., Giampietro P.F., and Auerbach A.D. Phenotypic consequences of mutations in the Fanconi anemia FAC gene: an International Fanconi Anemia Registry study. Blood 90 1 (1997) 105-110
9. Futaki M., Yamashita T., Yagasaki H., Toda T., Yabe M., Kato S., et al. The IVS4 + 4 A to T mutation of the fanconi anemia gene FANCC is not associated with a severe phenotype in Japanese patients. Blood 95 4 (2000) 1493-1498
10. Cassinat B., Guardiola P., Chevret S., Schlageter M.H., Toubert M.E., Rain J.D., et al. Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia. Blood 96 3 (2000) 859-863
11. Cassinat B., Darsin D., Guardiola P., Toubert M.E., Rain J.D., Gluckman E., et al. Intermethod discordance for alpha-fetoprotein measurements in Fanconi anemia. Clin. Chem. 47 8 (2001) 1405-1409
12. Schultz J.C., and Shahidi N.T. Tumor necrosis factor-alpha overproduction in Fanconi's anemia. Am. J. Hematol. 42 2 (1993) 196-201
13. Rosselli F., Sanceau J., Gluckman E., Wietzerbin J., and Moustacchi E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 83 5 (1994) 1216-1225
14. Alter B.P., Greene M.H., Velazquez I., and Rosenberg P.S. Cancer in Fanconi anemia. Blood 101 5 (2003) 2072
15. Hirsch B., Shimamura A., Moreau L., Baldinger S., Hag-alshiekh M., Bostrom B., et al. Association of biallelic BRCA2/FANCD1 mutations with spontaneous chromosomal instability and solid tumors of childhood. Blood 103 7 (2004) 2554-2559
16. Offit K., Levran O., Mullaney B., Mah K., Nafa K., Batish S.D., et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J. Natl. Cancer Inst. 95 20 (2003) 1548-1551
17. Auerbach A.D., Adler B., and Chaganti R.S. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method. Pediatrics 67 1 (1981) 128-135
18. Auerbach A.D. Fanconi anemia diagnosis and the diepoxybutane (DEB) test. Exp. Hematol. 21 6 (1993) 731-733
19. Berger R., Le Coniat M., and Gendron M.C. Fanconi anemia. Chromosome breakage and cell cycle studies. Cancer Genet. Cytogenet. 69 1 (1993) 13-16
20. Mathur R., Chowdhury M.R., and Singh G. Recent advances in chromosome breakage syndromes and their diagnosis. Indian Pediatr. 37 6 (2000) 615-625
21. Miglierina R., Le Coniat M., Gendron M., and Berger R. Diagnosis of Fanconi's anemia by flow cytometry. Nouv. Rev. Fr. Hematol. 32 6 (1990) 391-393
22. Miglierina R., Le Coniat M., and Berger R. A simple diagnostic test for Fanconi anemia by flow cytometry. Anal. Cell. Pathol. 3 2 (1991) 111-118
23. Gregory Jr. J.J., Wagner J.E., Verlander P.C., Levran O., Batish S.D., Eide C.R., et al. Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 98 5 (2001) 2532-2537
24. Carreau M., Liu L., Gan O.I., Hitzler J.K., Dick J.E., and Buchwald M. Short-term granulocyte colony-stimulating factor and erythropoietin treatment enhances hematopoiesis and survival in the mitomycin C-conditioned Fancc(-/-) mouse model, while long-term treatment is ineffective. Blood 100 4 (2002) 1499-1501
25. Claustres M., Margueritte G., and Sultan C. In vitro CFU-E and BFU-E responses to androgen in bone marrow from children with primary hypoproliferative anaemia: a possible therapeutic assay. Eur. J. Pediatr. 144 5 (1986) 467-471
26. Gurtan A.M., Stuckert P., and D'Andrea A.D. The WD40-repeats of FANCL are required for Fanconi anemia core complex assembly. J. Biol. Chem. 10 (2006) 10
27. Guinan E.C., Lopez K.D., Huhn R.D., Felser J.M., and Nathan D.G. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of pancytopenia in children with fanconi anemia. J. Pediatr. 124 1 (1994) 144-150
28. Lopez K.D., and Guinan E.C. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia. Pediatr. Nurs. 21 4 (1995) 345-349
29. Rackoff W.R., Orazi A., Robinson C.A., Cooper R.J., Alter B.P., Freedman A., et al. Prolonged administration of granulocyte colonystimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study. Blood 88 5 (1996) 1588-1593
30. Scagni P., Saracco P., Timeus F., Farinasso L., Dall'Aglio M., Bosa E.M., et al. Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia. Haematologica 83 5 (1998) 432-437
31. Schmidt E., Deeg H.J., and Storb R. Regression of androgen-related hepatic tumors in patients with Fanconi's anemia following marrow transplantation. Transplantation 37 5 (1984) 452-455
32. Touraine R.L., Bertrand Y., Foray P., Gilly J., and Philippe N. Hepatic tumours during androgen therapy in Fanconi anaemia. Eur. J. Pediatr. 152 8 (1993) 691-693
33. Gluckman E., Auerbach A.D., Horowitz M.M., Sobocinski K.A., Ash R.C., Bortin M.M., et al. Bone marrow transplantation for Fanconi anemia. Blood 86 7 (1995) 2856-2862
34. Socie G., Devergie A., Girinski T., Piel G., Ribaud P., Esperou H., et al. Transplantation for Fanconi's anaemia: long-term follow-up of fifty patients transplanted from a sibling donor after low-dose cyclophosphamide and thoraco-abdominal irradiation for conditioning. Br. J. Haematol. 103 1 (1998) 249-255
35. Guardiola P., Pasquini R., Dokal I., Ortega J.J., van Weel-Sipman M., Marsh J.C., et al. Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood 95 2 (2000) 422-429
36. Gluckman E., Broxmeyer H.A., Auerbach A.D., Friedman H.S., Douglas G.W., Devergie A., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321 17 (1989) 1174-1178
37. Gluckman E., Auerbach A., Ash R.C., Biggs J.C., Bortin M.M., Camitta B.M., et al. Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 10 Suppl 1 (1992) 53-57
38. Socie G., Gluckman E., Raynal B., Petit T., Landman J., Devergie A., et al. Bone marrow transplantation for Fanconi anemia using lowdose cyclophosphamide/thoracoabdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood 82 7 (1993) 2249-2256
39. Gluckman E., Devergie A., Schaison G., Bussel A., Berger R., Sohier J., et al. Bone marrow transplantation in Fanconi anaemia. Br. J. Haematol. 45 4 (1980) 557-564
40. Grewal S.S., Kahn J.P., MacMillan M.L., Ramsay N.K., and Wagner J.E. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 103 3 (2004) 1147-1151
41. Mankad A., Taniguchi T., Cox B., Akkari Y., Rathbun R.K., Lucas L., et al. Natural gene therapy in monozygotic twins with Fanconi anemia. Blood 5 (2006) 5
42. Duckworth-Rysiecki G., Cornish K., Clarke C.A., and Buchwald M. Identification of two complementation groups in Fanconi anemia. Somat. Cell Mol. Genet. 11 1 (1985) 35-41
43. Joenje H., Oostra A.B., Wijker M., di Summa F.M., van Berkel C.G., Rooimans M.A., et al. Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet. 61 4 (1997) 940-944
44. Levitus M., Rooimans M.A., Steltenpool J., Cool N.F., Oostra A.B., Mathew C.G., et al. Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. Blood 103 7 (2004) 2498-2503
45. Strathdee C.A., Duncan A.M., and Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9. Nat. Genet. 1 3 (1992) 196-198
46. Levitus M., Waisfisz Q., Godthelp B.C., de Vries Y., Hussain S., Wiegant W.W., et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37 9 (2005) 934-935
47. Litman R., Peng M., Jin Z., Zhang F., Zhang J., Powell S., et al. BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell 8 3 (2005) 255-265
48. Lo Ten Foe J.R., Rooimans M.A., Bosnoyan-Collins L., Alon N., Wijker M., Parker L., et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat. Genet. 14 3 (1996) 320-323
49. Meetei A.R., Medhurst A.L., Ling C., Xue Y., Singh T.R., Bier P., et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet. 37 9 (2005) 958-963
50. Meetei A.R., Yan Z., and Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 3 2 (2004) 179-181
51. Meetei A.R., Levitus M., Xue Y., Medhurst A.L., Zwaan M., Ling C., et al. X-linked inheritance of Fanconi anemia complementation group B. Nat Genet 36 11 (2004) 1219-1224
52. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 35 2 (2003) 165-170
53. The Fanconi anemia/Breast Cancer consortium. Positional cloning of the Fanconi anaemia group A gene. Nat. Genet. 14 3 (1996) 324-328
54. de Winter J.P., Rooimans M.A., van Der Weel L., van Berkel C.G., Alon N., Bosnoyan-Collins L., et al. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat. Genet. 24 1 (2000) 15-16
55. de Winter J.P., Leveille F., van Berkel C.G., Rooimans M.A., van Der Weel L., Steltenpool J., et al. Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am. J. Hum. Genet. 67 5 (2000) 1306-1308
56. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297 5581 (2002) 606-609
57. Strathdee C.A., Gavish H., Shannon W.R., and Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 358 6385 (1992) 434
58. Timmers C., Taniguchi T., Hejna J., Reifsteck C., Lucas L., Bruun D., et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol. Cell 7 2 (2001) 241-248
59. Castillo V., Cabre O., Marcos R., and Surralles J. Molecular cloning of the Drosophila Fanconi anaemia gene FANCD2 cDNA. DNA Repair (Amst.) 2 6 (2003) 751-758
60. Ferrer M., Rodriguez J.A., Spierings E.A., de Winter J.P., Giaccone G., and Kruyt F.A. Identification of multiple nuclear export sequences in Fanconi anemia group A protein that contribute to CRM1-dependent nuclear export. Hum. Mol. Genet. 14 10 (2005) 1271-1281
61. Blom E., van de Vrugt H.J., de Vries Y., de Winter J.P., Arwert F., and Joenje H. Multiple TPR motifs characterize the Fanconi anemia FANCG protein. DNA Repair (Amst.) 3 1 (2004) 77-84
62. Lightfoot J., Alon N., Bosnoyan-Collins L., and Buchwald M. Characterization of regions functional in the nuclear localization of the Fanconi anemia group A protein. Hum. Mol. Genet. 8 6 (1999) 1007-1015
63. Mosedale G., Niedzwiedz W., Alpi A., Perrina F., Pereira-Leal J.B., Johnson M., et al. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol. 12 9 (2005) 763-771
64. Kennedy R.D., and D'Andrea A.D. The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev. 19 24 (2005) 2925-2940
65. Pichierri P., and Rosselli F. The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways. EMBO J. 26 (2004) 26
66. Taniguchi T., Garcia-Higuera I., Xu B., Andreassen P.R., Gregory R.C., Kim S.T., et al. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 109 4 (2002) 459-472
67. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7 2 (2001) 249-262
68. Gordon S.M., and Buchwald M. Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood 102 1 (2003) 136-141
69. Pace P., Johnson M., Tan W.M., Mosedale G., Sng C., Hoatlin M., et al. FANCE: the link between Fanconi anaemia complex assembly and activity. EMBO J. 21 13 (2002) 3414-3423
70. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., et al. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 13 12 (2004) 1241-1248
71. Hussain S., Witt E., Huber P.A., Medhurst A.L., Ashworth A., and Mathew C.G. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet. 5 (2003) 5
72. Ohashi A., Zdzienicka M.Z., Chen J., and Couch F.J. Fanconi Anemia Complementation Group D2 (FANCD2) Functions Independently of BRCA2- and RAD51-associated Homologous Recombination in Response to DNA Damage. J Biol Chem 280 15 (2005) 14877-14883
73. Taniguchi T., Garcia-Higuera I., Andreassen P.R., Gregory R.C., Grompe M., and D'Andrea A.D. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood 100 7 (2002) 2414-2420
74. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., et al. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 23 7 (2002) 1121-1126
75. Godthelp B.C., Artwert F., Joenje H., and Zdzienicka M.Z. Impaired DNA damage-induced nuclear Rad51 foci formation uniquely characterizes Fanconi anemia group D1. Oncogene 21 32 (2002) 5002-5005
76. Otsuki T., Furukawa Y., Ikeda K., Endo H., Yamashita T., Shinohara A., et al. Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. Hum. Mol. Genet. 10 23 (2001) 2651-2660
77. Meetei A.R., Sechi S., Wallisch M., Yang D., Young M.K., Joenje H., et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell. Biol. 23 10 (2003) 3417-3426
78. Pichierri P., Franchitto A., and Rosselli F. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. Embo. J. 23 15 (2004) 3154-3163
79. Davies A.A., Masson J.Y., McIlwraith M.J., Stasiak A.Z., Stasiak A., Venkitaraman A.R., et al. Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell 7 2 (2001) 273-282
80. Pichierri P., Averbeck D., and Rosselli F. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum. Mol. Genet. 11 21 (2002) 2531-2546
81. Fagerlie S., Lensch M.W., Pang Q., and Bagby Jr. G.C. The Fanconi anemia group C gene product: signaling functions in hematopoietic cells. Exp. Hematol. 29 12 (2001) 1371-1381
82. Pang Q., Christianson T.A., Keeble W., Diaz J., Faulkner G.R., Reifsteck J., et al. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality. Blood 98 5 (2001) 1392-1401
83. Pagano G., and Youssoufian H. Fanconi anaemia proteins: major roles in cell protection against oxidative damage. Bioessays 25 6 (2003) 589-595
84. Nordenson I. Effect of superoxide dismutase and catalase on spontaneously occurring chromosome breaks in patients with Fanconi's anemia. Hereditas 86 2 (1977) 147-150
85. Dallapiccola B., Porfirio B., Mokini V., Alimena G., Isacchi G., and Gandini E. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes. Hum. Genet. 69 1 (1985) 62-65
86. Gille J.J., Wortelboer H.M., and Joenje H. Antioxidant status of Fanconi anemia fibroblasts. Hum. Genet. 77 1 (1987) 28-31
87. Joenje H., Eriksson A.W., Frants R.R., Arwert F., and Houwen B. Erythrocyte superoxide-dismutase deficiency in Fanconi's anaemia. Lancet 1 8057 (1978) 204
88. Yoshimitsu K., Kobayashi Y., and Usui T. Decreased superoxide dismutase activity of erythrocytes and leukocytes in Fanconi's anemia. Acta Haematol. 72 3 (1984) 208-210
89. Degan P., Bonassi S., De Caterina M., Korkina L.G., Pinto L., Scopacasa C., et al. In vivo accumulation of 8-hydroxy-2'-deoxyguanosine in DNA correlates with release of reactive oxygen species in Fanconi's anaemia families. Carcinogenesis 16 4 (1995) 735-741
90. Cumming R.C., Lightfoot J., Beard K., Youssoufian H., O'Brien P.J., and Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 7 7 (2001) 814-820
91. Futaki M., Igarashi T., Watanabe S., Kajigaya S., Tatsuguchi A., Wang J., et al. The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 23 1 (2002) 67-72
92. Kruyt F.A., Hoshino T., Liu J.M., Joseph P., Jaiswal A.K., and Youssoufian H. Abnormal microsomal detoxification implicated in Fanconi anemia group C by interaction of the FAC protein with NADPH cytochrome P450 reductase. Blood 92 9 (1998) 3050-3056
93. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts II L.J., et al. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. USA 96 17 (1999) 9915-9919
94. Kamsler A., Daily D., Hochman A., Stern N., Shiloh Y., Rotman G., et al. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61 5 (2001) 1849-1854
95. Yan M., Qiang W., Liu N., Shen J., Lynn W.S., and Wong P.K. The ataxia-telangiectasia gene product may modulate DNA turnover and control cell fate by regulating cellular redox in lymphocytes. FASEB J. 15 7 (2001) 1132-1138
96. Reichenbach J., Schubert R., Schindler D., Muller K., Bohles H., and Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4 3 (2002) 465-469
97. Vuillaume M., Calvayrac R., Best-Belpomme M., Tarroux P., Hubert M., Decroix Y., et al. Deficiency in the catalase activity of xeroderma pigmentosum cell and simian virus 40-transformed human cell extracts. Cancer Res. 46 2 (1986) 538-544
98. Vuillaume M., Daya-Grosjean L., Vincens P., Pennetier J.L., Tarroux P., Baret A., et al. Striking differences in cellular catalase activity between two DNA repair-deficient diseases: xeroderma pigmentosum and trichothiodystrophy. Carcinogenesis 13 3 (1992) 321-328
99. Arbault S., Sojic N., Bruce D., Amatore C., Sarasin A., and Vuillaume M. Oxidative stress in cancer prone xeroderma pigmentosum fibroblasts. Real-time and single cell monitoring of superoxide and nitric oxide production with microelectrodes. Carcinogenesis 25 4 (2004) 509-515
100. Saito H., Hammond A.T., and Moses R.E. Hypersensitivity to oxygen is a uniform and secondary defect in Fanconi anemia cells. Mutat. Res. 294 3 (1993) 255-262
101. Zanier R., Briot D., Dugas du Villard J.A., Sarasin A., and Rosselli F. Fanconi anemia C gene product regulates expression of genes involved in differentiation and inflammation. Oncogene 23 29 (2004) 5004-5013
102. Otsuki T., Nagakura S., Wang J., Bloom M., Grompe M., and Liu J.M. Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice. J. Cell. Physiol. 179 1 (1999) 79-86
103. Dufour C., Corcione A., Svahn J., Haupt R., Poggi V., Beka'ssy A.N., et al. TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro. Blood 102 6 (2003) 2053-2059
104. Liu Z.G. Molecular mechanism of TNF signaling and beyond. Cell Res. 15 1 (2005) 24-27
105. Futaki M., Watanabe S., Kajigaya S., and Liu J.M. Fanconi anemia protein, FANCG, is a phosphoprotein and is upregulated with FANCA after TNF-alpha treatment. Biochem. Biophys. Res. Commun. 281 2 (2001) 347-351